G H Tesch Selected Research

G H Tesch Research Topics

Disease

8	Fibrosis (Cirrhosis) 03/2014 - 10/2001
8	Inflammation (Inflammations) 03/2014 - 11/2000
4	Diabetic Nephropathies (Diabetic Nephropathy) 04/2008 - 07/2004
3	Albuminuria 08/2009 - 01/2006
2	Hypertrophy 08/2009 - 02/2009
2	Type 2 Diabetes Mellitus (MODY) 04/2008 - 02/2007
2	Proteinuria 09/2007 - 10/2001
2	Glomerulonephritis 09/2007 - 10/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2014
1	Hypertension (High Blood Pressure) 03/2014
1	Obesity 02/2009
1	Renal Insufficiency (Renal Failure) 04/2008
1	Sclerosis 10/2007
1	Diabetes Complications 10/2007
1	Acute Disease 09/2007
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2004
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 10/2001
1	Disease Progression 10/2001
1	Vasculitis (Vasculitides) 10/2001
1	Kidney Diseases (Kidney Disease) 11/2000
1	Neoplasm Metastasis (Metastasis) 09/2000

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 08/2009 - 11/2000
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 03/2014 - 04/2008
2	Advanced Glycation End ProductsIBA 02/2011 - 01/2006
2	Messenger RNA (mRNA)IBA 08/2009 - 02/2009
2	CC ChemokinesIBA 08/2009 - 04/2008
2	p38 Mitogen-Activated Protein KinasesIBA 02/2009 - 07/2004
2	antiglomerular basement membrane antibodyIBA 09/2007 - 10/2001
2	Streptozocin (Streptozotocin)FDA Link 01/2006 - 07/2004
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 03/2014
1	MineralocorticoidsIBA 03/2014
1	SaltsIBA 03/2014
1	AldosteroneIBA 01/2012
1	Receptor for Advanced Glycation End ProductsIBA 02/2011
1	betaglycan (TGFBR3)IBA 02/2011
1	pirfenidoneIBA 02/2011
1	Omacor FDA Link 02/2011
1	alagebriumIBA 02/2011
1	aliskiren FDA Link 02/2011
1	SMP-534IBA 02/2011
1	Eplerenone (Inspra)FDA LinkGeneric 02/2011
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2011
1	Biliverdine (Biliverdin)IBA 02/2011
1	LipidsIBA 02/2011
1	Phosphotransferases (Kinase)IBA 02/2011
1	PyridoxamineIBA 02/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2011
1	Antisense OligonucleotidesIBA 02/2011
1	Plasminogen Activator Inhibitor 1IBA 02/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2011
1	Chemokine ReceptorsIBA 02/2011
1	Nucleotide AptamersIBA 02/2011
1	Angiotensin Receptor AntagonistsIBA 02/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009
1	Activating Transcription Factor 2IBA 08/2009
1	Monoclonal AntibodiesIBA 08/2009
1	Proteins (Proteins, Gene)FDA Link 08/2009
1	Immunoglobulin G (IgG)IBA 08/2009
1	JNK Mitogen-Activated Protein KinasesIBA 08/2009
1	ChemokinesIBA 04/2008
1	Fibronectins (Fibronectin)IBA 01/2008
1	CytokinesIBA 10/2007
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2007
1	Peptide Hydrolases (Proteases)FDA Link 10/2007
1	CC 401IBA 09/2007
1	Chemotactic FactorsIBA 02/2007
1	Glucose (Dextrose)FDA LinkGeneric 01/2006
1	CreatinineIBA 01/2006
1	CollagenIBA 07/2004
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2001
1	LF 150195IBA 10/2001
1	Protein Isoforms (Isoforms)IBA 09/2000

Therapy/Procedure

2	Therapeutics 04/2008 - 10/2001
1	Investigational Therapies (Experimental Therapy) 10/2007
1	Subcutaneous Injections 10/2001